Brittle polymers in Fused Deposition Modeling: An improved feeding approach to enable the printing of highly drug loaded filament.

Additive manufacturing Feedability Fused deposition modeling High drug load Immediate release Mechanical properties

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
15 Mar 2021
Historique:
received: 22 10 2020
revised: 18 12 2020
accepted: 21 12 2020
pubmed: 26 1 2021
medline: 22 6 2021
entrez: 25 1 2021
Statut: ppublish

Résumé

Brittleness is often described as a restricting material property for the processability of filaments via Fused Deposition Modeling. Especially filaments produced from approved pharmaceutical polymers often tend to fracture between feeding gears, the commonly employed feeding mechanism. In order to enhance their mechanical properties, usually extensive formulation development is performed. This study presents a different strategy to enable the printing of brittle filaments without the use of additional excipients by adapting the feeding mechanism to piston feeding. The polymers Soluplus®, Kollidon® VA64 and Eudragit® E PO were used, which have been reported to be brittle. Ketoconazole was used as model compound at 40% drug load and the influence on the mechanical properties was investigated using the three-point flexural test. In order to gain a better understanding of the mechanism affecting brittleness, filaments were analyzed in terms of crystallinity and miscibility of the components using polarized microscopy, differential scanning calorimetry and X-ray diffraction. Printing was performed with the aim to obtain immediate release tablets. The addition of Ketoconazole resulted in filaments even more brittle than placebo filaments. Nevertheless, the adaption of the feeding mechanism enabled the successful manufacturing of uniform tablets from all formulations.

Identifiants

pubmed: 33493597
pii: S0378-5173(21)00020-X
doi: 10.1016/j.ijpharm.2021.120216
pii:
doi:

Substances chimiques

Excipients 0
Polymers 0
Tablets 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

120216

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Nadine Gottschalk (N)

Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Düsseldorf, Germany; Department of Pharmaceutical Technologies, Merck KGaA, Darmstadt, Germany.

Malte Bogdahn (M)

Department of Pharmaceutical Technologies, Merck KGaA, Darmstadt, Germany. Electronic address: malte.bogdahn@merckgroup.com.

Meike Harms (M)

Department of Pharmaceutical Technologies, Merck KGaA, Darmstadt, Germany.

Julian Quodbach (J)

Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Düsseldorf, Germany.

Articles similaires

Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Semiconductors Photosynthesis Polymers Carbon Dioxide Bacteria
Animals Huntington Disease Mitochondria Neurons Mice

Characterization of 3D printed composite for final dental restorations.

Lucas Eigi Borges Tanaka, Camila da Silva Rodrigues, Manassés Tércio Vieira Grangeiro et al.
1.00
Composite Resins Materials Testing Printing, Three-Dimensional Surface Properties Flexural Strength

Classifications MeSH